Merck (MRK) EPS (Basic) Growth (5y) (2014 - 2026)
Powered by 
Analysis
Merck (MRK) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.94 Bn | 621.19 Bn | 17.26 Bn |
| 2 | AbbVie | 446.83 Bn | 440.26 Bn | 12.70 Bn |
| 3 | Merck | 358.00 Bn | 350.86 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.50 Bn | 259.81 Bn | 11.24 Bn |
| 5 | Pfizer | 156.75 Bn | 145.05 Bn | 10.94 Bn |
| 6 | Sanofi | 52.23 Bn | 44.85 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.93 Bn | 42.93 Bn | - |
| 8 | Incyte | 24.64 Bn | 20.10 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.35 Bn | 18.68 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.86 Bn | 15.47 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.62% |
| Mar 31, 2026 | -27.46% |
| Dec 31, 2025 | 27.97% |
| Sep 30, 2025 | 14.78% |
| Jun 30, 2025 | 8.17% |
| Mar 31, 2025 | 9.66% |
| Dec 31, 2024 | 32.59% |
| Sep 30, 2024 | 10.84% |
| Jun 30, 2024 | 15.97% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | -22.19% |
| Sep 30, 2023 | 20.55% |
| Jun 30, 2023 | -41.52% |
| Mar 31, 2023 | 32.27% |
| Dec 31, 2022 | 38.71% |
| Sep 30, 2022 | 134.34% |
| Jun 30, 2022 | 16.94% |
| Mar 31, 2022 | 24.62% |
| Dec 31, 2021 | 55.21% |
| Sep 30, 2021 | 17.95% |